MEDP · Medpace Holdings, Inc. · Executive Compensation
$587.52
+4.36 (+0.75%)
At close · Sep 11
Market Cap
$16.40B
Shares
27.91M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| August Troendle | CEO | $11,443,766 |
| August J. Troendle | Chief Executive Officer | $11,443,766 |
| Susan E. Burwig | Executive Vice President, Operations | $2,723,814 |
| Jesse Geiger | President | $2,396,370 |
| Stephen P. Ewald | General Counsel and Corporate Secretary | $2,019,709 |
| Kevin Brady | Chief Financial Officer and Treasurer | $1,646,197 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| August J. Troendle | Chief Executive Officer | $8,600,016 |
| August Troendle | CEO | $8,600,016 |
| Susan E. Burwig | Executive Vice President, Operations | $4,834,069 |
| Jesse Geiger | President | $4,709,067 |
| Stephen P. Ewald | General Counsel and Corporate Secretary | $3,699,450 |
| Kevin Brady | Chief Financial Officer and Treasurer | $3,484,250 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| August J. Troendle | Chief Executive Officer | $1,646,031 |
| August Troendle | CEO | $1,646,031 |
| Susan E. Burwig | Executive Vice President, Operations | $1,124,299 |
| Jesse Geiger | President | $945,078 |
| Stephen P. Ewald | General Counsel and Corporate Secretary | $914,643 |
| Kevin Brady | Chief Financial Officer and Treasurer | $690,481 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| August Troendle | CEO | $1,885,034 |
| August J. Troendle | Chief Executive Officer | $1,885,034 |
| Susan E. Burwig | Executive Vice President, Operations | $1,210,739 |
| Jesse Geiger | President | $1,083,377 |
| Stephen P. Ewald | General Counsel and Corporate Secretary | $1,032,627 |
| Kevin Brady | Chief Financial Officer and Treasurer | $843,043 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| August J. Troendle | Chief Executive Officer | $5,947,423 |
| August Troendle | CEO | $5,947,423 |
| Susan E. Burwig | Executive Vice President, Operations | $2,522,346 |
| Jesse Geiger | President | $2,306,109 |
| Stephen P. Ewald | General Counsel and Corporate Secretary | $1,859,091 |
| Kevin Brady | Chief Financial Officer and Treasurer | $1,200,463 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| August Troendle | CEO | $4,136,810 |
| August J. Troendle | Chief Executive Officer | $4,136,810 |
| Susan E. Burwig | Executive Vice President, Operations | $1,952,124 |
| Jesse Geiger | President | $1,880,070 |
| Stephen P. Ewald | General Counsel and Corporate Secretary | $1,539,023 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| August Troendle | — | $7,712,835 |
| August J. Troendle | Chief ExecutiveOfficer | $7,712,835 |
| Susan E. Burwig | Executive Vice President,Operations | $2,429,461 |
| Jesse Geiger | President | $1,883,882 |
| Stephen P. Ewald | General Counsel andCorporate Secretary | $1,253,572 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Susan E. Burwig | Executive Vice President, Operations | $729,750 |
| Jesse Geiger | Chief Financial Officer and Chief Operating Officer, Laboratory Operations | $676,538 |
| August Troendle | CEO | $528,290 |
| August J. Troendle | President and Chief Executive Officer | $528,290 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Susan E. Burwig | Executive Vice President, Operations | $693,464 |
| Jesse Geiger | Chief Financial Officer and Chief Operating Officer, Laboratory Operations | $658,000 |
| August Troendle | CEO | $598,083 |
| August J. Troendle | President and Chief Executive Officer | $598,083 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Brad W. Hansman | Executive Vice President, Operations | Appointed | 2026-06-04 |
| Jesse Geiger | President | Resigned | 2026-04-22 |
| Dani S. Zander | Class III Director | Appointed | 2025-05-16 |
| August J. Troendle | Class III Director | Appointed | 2025-05-16 |
Key facts
CIK
1668397
CUSIP
58506Q109
13F (30d)
151 filings
150 filers
Visit website
Investor relations